Drawing for NOVOSIS

USPTO serial 99250754

NOVOSIS

Reviewed by CopyMark Law Group

Status 774
Filing date
Status date
Registration date
—
Examiner
CHUNG, DIANA ALANA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NOVOSIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CAROLINE E. BRYCE

CAROLINE E. BRYCE SHERIDAN ROSS P.C.1560 BROADWAYSUITE 1200DENVER, CO 80202

Goods and services

ClassDescriptionStatusFirst use
005Implants comprising living tissue; surgical implants comprising living tissues for transplant purposes; bone morphogenetic protein for use as a bone growth media for medical or veterinary purposes; bone cement for surgical and orthopaedic purposes; bone growth media consisting of biological materials for medical purposes; bone fillers consisting of living materials; surgical implants comprised of living tissues; dental adhesives; bone cement for medical purposes; bone void fillers comprised of living tissues; human allogeneic tissue; medicinal preparations for preventing osteoporosis and to facilitate bone growth; pharmaceutical preparations for the treatment of bone fractures and to facilitate bone growth; syringes sold filled with pharmaceutical preparations to facilitate bone growthACTIVE—
010Medical apparatus and instruments to facilitate bone growth, namely, orthopedic fixation device used in orthopedic transplant or implant surgery; medical bone graft materials, namely, synthetic bone grafts; implants being prostheses for use in bone grafting, namely, bone substitutes for surgical use; artificial bones for implantation; artificial bone parts to be implanted in natural bones; injection device for pharmaceuticals to facilitate bone growth; bone void fillers comprised of artificial materials; bone implants composed of artificial materials; surgical bone cementation tools and equipment, namely, surgical devices and instruments; substitutes for bones, cartilage, ligaments and tendons; dental implants made of artificial materials; artificial bone growth media; prosthetic and filling materials, namely, putty for use in the replacement of bonesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Oct 28, 2026OP.IOPPOSITION INSTITUTED NO. 999999—
Oct 21, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 21, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 7, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 30, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 30, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 24, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 30, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 27, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 27, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Feb 26, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Nov 29, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2025DOCKASSIGNED TO EXAMINER—
Oct 31, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 24, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 24, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance